Log in to search using one of your social media accounts:

 

What Charlotte Rae's Cancer Plan Reveals About Medical Decisions Late In Life
Actress Charlotte Rae, 91, has revealed that she was just diagnosed with bone cancer. And like many who get a diagnosis of a serious illness at an advanced age, her first decision wasn’t what the best treatment plan might be but rather whether she should seek treatment at all. “At the age of 91, I have to make up my mind,” she told People magazine. “I’m not in any pain right now. I’m feeling so terrific and so glad to be above ground.” Rae, who was treated for pancreatic cancer several years ago, added, “Now I have to figure out whether I want to go have treatment again ...
Source: Healthy Living - The Huffington Post - April 28, 2017 Category: Consumer Health News Source Type: news

Primary Intracranial Extraskeletal Chondrosarcoma Primary Intracranial Extraskeletal Chondrosarcoma
This patient's MRI scan revealed a mass which was initially misdiagnosed as a meningioma. What imaging features might have pointed to its true etiology?Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 3, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Schoolboy has jaw built using his LEG BONES after tumour ravaged his face
Adam McCalmont, 16, from Coleraine, Northern Ireland, was diagnosed with mesenchymal chondrosarcoma - a rare form of bone cancer - after complaining of a dull ache in his jaw. (Source: the Mail online | Health)
Source: the Mail online | Health - December 12, 2016 Category: Consumer Health News Source Type: news

Studies point to clinical advantages of proton therapy
New data from clinical trials demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 19, 2015 Category: Science Source Type: news

ASTRO: Penn Medicine studies point to clinical advantages of proton therapy
(University of Pennsylvania School of Medicine) New data from clinical trials conducted at the Robert Proton Therapy Center demonstrate the technology's potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2015 Category: Cancer & Oncology Source Type: news

South African woman whose face was DEVOURED by cancer
Tambu Makinzi, 27, from South Africa, was diagnosed with the rare bone cancer chondrosarcoma four years ago. It devoured her nasal and upper jaw bone, leaving her months from death. (Source: the Mail online | Health)
Source: the Mail online | Health - September 11, 2015 Category: Consumer Health News Source Type: news

Survival from rare bone cancer remains low
Ten-year survival of a rare malignancy called mesenchymal chondrosarcoma has been reported to be as low as 20 percent. But a new study has found survival is not as dismal as prior reports. More than half (51 percent) of patients survived at least five years, and 43 percent survived at least 10 years. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2015 Category: Science Source Type: news

Survival from rare bone cancer remains low
(Loyola University Health System) Among the deadliest cancers is a rare malignancy called mesenchymal chondrosarcoma, which begins in cartilage around bones and typically strikes young adults. Ten-year survival has been reported to be as low as 20 percent. But a Loyola study has found survival is not as dismal as prior reports. Fifty-one percent of patients survived at least five years, and 43 percent survived at least 10 years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 12, 2015 Category: Cancer & Oncology Source Type: news

Missouri hospital delivers world’s first proton therapy treatment using MEVION S250
Barnes-Jewish Hospital, a member of BJC HealthCare, has delivered the world’s first MEVION S250 proton therapy treatment to a patient with a rare type of cancer called chondrosarcoma at the base of the skull. (Source: Hospital Management)
Source: Hospital Management - December 24, 2013 Category: Hospital Management Source Type: news